What the research shows about tirzepatide and lean mass A systematic review published in 2025 examining tirzepatide effects on skeletal muscle mass found that lean tissue loss accounts for 20% to 34% of total weight lost during treatment
Cold fluid entering warm tissue causes vasoconstriction (blood vessel narrowing) at the injection site, which can slow initial absorption and increase the sensation of pressure
In that case, a dermatological assessment after 6 to 9 months is strongly recommended
They can perform a blood test to assess your B12 levels, identify the underlying cause of any deficiency, and recommend the most appropriate treatment for your health needs
I did a lot of research before taking the leap to start medication, but I am glad I started
Women should discuss pregnancy plans or current pregnancy, as tirzepatide is not recommended during pregnancy due to potential fetal harm